Adma Biologics Inc Reports Results For The Quarter Ended In June: Earnings Summary

ADMA Biologics

10/08/2022 22:01

* ADMA Biologics Inc  ADMA.OQ  reported a quarterly adjusted
loss
of 7 cents​​ per share for the quarter ended in June. The mean
expectation of three analysts for the quarter was for a loss
of 8 cents per share.
    * Revenue rose 90.1% to $33.91 million from a year ago;
analysts
expected $31.81 million. 
    * ADMA Biologics Inc's reported EPS for the quarter was a
loss
of 7 cents​.
    * The mean earnings estimate of analysts had fallen by
about 6.7%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * ADMA Biologics Inc shares had risen by 2.5% this
quarter and
gained 44.0% so far this year.
    * The company reported a quarterly loss of $13.76 million.
    * Wall Street's median 12-month price target for ADMA
Biologics
Inc is $4.75 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 10
at 09:00 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.08          -0.07          Beat
 Mar. 31 2022      -0.08          -0.10          Missed
 Dec. 31 2021      -0.09          -0.09          Met
 Sep. 30 2021      -0.14          -0.13          Beat